LungLifeAI Logo

Result of AGM

June 5, 2024

LungLife AI, Inc.

("LungLife" or the "Company")

Result of Annual General Meeting

LungLife AI (AIM: LLAI), a developer of clinical diagnostic solutions for lung cancer, announces that at its Annual General Meeting, held at earlier today, all 10 resolutions put to members were passed on a poll.

Full details of the voting will be available shortly on the Company website here:

For further information please contact:

LungLife AI,
Paul Pagano, CEO Via Walbrook PR
David Anderson, CFO 
Investec Bank plc (Nominated Adviser & Broker)Tel: +44 (0)20 7597 5970
Virginia Bull / Cameron MacRitchie / Lydia Zychowska
Goodbody (Joint Broker)Tel: +44 (0) 20 3841 6202
Tom Nicholson / Cameron Duncan 
Walbrook PR LimitedTel: +44 (0)20 7933 8780 or
Alice Woodings / Phillip MarriageMob: 07407 804 654 / 07867 984 082

Click HERE for the full announcement.

Recent News

Subscribe for Email Alerts

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

LungLifeAI Logo
LungLife AI licensure/accreditation information posted here.
© 2023 LungLIfe AI, Inc.
All rights reserved. LiquidBiopsy is a trademark of LungLife AI, Inc.